Current and Emerging Therapies in NSCLC

home / peer-exchange / nsclc-therapies
Case Study: Treating an Elderly Patient With Squamous NSCLC

EP. 1: Case Study: Treating an Elderly Patient With Squamous NSCLC

August 21st 2013
Case Study: Maintenance Therapy in Squamous NSCLC

EP. 2: Case Study: Maintenance Therapy in Squamous NSCLC

August 21st 2013
Case Study: Mutation-Negative Patient With Adenocarcinoma

EP. 3: Case Study: Mutation-Negative Patient With Adenocarcinoma

August 21st 2013
PRONOUNCE Trial: Two Drug Versus Three Drug Regimens

EP. 4: PRONOUNCE Trial: Two Drug Versus Three Drug Regimens

August 21st 2013
Case Study: Second-Line Treatment of Adenocarcinoma

EP. 5: Case Study: Second-Line Treatment of Adenocarcinoma

August 21st 2013
Case Study: MET and ALK Targeted Therapies in NSCLC

EP. 6: Case Study: MET and ALK Targeted Therapies in NSCLC

August 21st 2013
Case Study: Progression on ALK Inhibitors in NSCLC

EP. 7: Case Study: Progression on ALK Inhibitors in NSCLC

August 21st 2013
Case Study: Treating KRAS-Mutant Adenocarcinoma

EP. 8: Case Study: Treating KRAS-Mutant Adenocarcinoma

August 21st 2013
Targeting the Immune System in Non-Small Cell Lung Cancer

EP. 9: Targeting the Immune System in Non-Small Cell Lung Cancer

August 21st 2013
Novel Immunotherapy Combinations in NSCLC

EP. 10: Novel Immunotherapy Combinations in NSCLC

August 21st 2013
GALAXY-1 Trial: Investigation of Hsp90 Inhibition in NSCLC

EP. 11: GALAXY-1 Trial: Investigation of Hsp90 Inhibition in NSCLC

August 21st 2013
Selecting a First-Line EGFR Inhibitor in NSCLC

EP. 12: Selecting a First-Line EGFR Inhibitor in NSCLC

August 21st 2013
Conclusion: Final Thoughts on Treatment Advances in NSCLC

EP. 13: Conclusion: Final Thoughts on Treatment Advances in NSCLC

August 21st 2013